COVID-19 booster vaccination/booster vaccination

In the practice of DR. FRÜHWEIN & PARTNER in Munich

COVID-19 vaccines offer effective and lasting protection against severe illness and death from SARS-COV-2, even if infection cannot be ruled out with certainty. Nevertheless, the risk of infection with COVID-19 is reduced and thus the risk of transmission to contact persons is also minimized. Unvaccinated persons are thus particularly at risk. As with most vaccinations, vaccine protection wears off over time, especially in terms of preventing infections without symptoms or with mild courses of disease. Vaccinations are less effective in older or immunocompromised patients due to the limited immune response, which is why vaccination breakthroughs can lead to more severe courses of the disease.

Which vaccine composition?

The WHO regularly updates its recommendations on the composition of COVID-19 vaccines. As the virus is constantly changing and new variants are always circulating, an adjustment is always necessary to ensure adequate protection. A vaccine against variant JN.1 is recommended for the 2024/2025 season. According to current data, the vaccine also provides good protection against the other circulating variants.

COVID-19 booster vaccination / booster vaccination

Available booster vaccines against COVID-19

The following vaccines are available in Germany this season:


<h2>Comirnaty; mRNA</h2>
<h3>Biontech / Pfizer</h3>

Touch with the mouse pointer for more information.


<h2>Comirnaty</h2>
<h3>Biontech / Pfizer</h3>

Trade name: Comirnaty Manufacturer: Biontech/Pfizer Type of vaccine: mRNA Approval since: 21.12.2020 Comirnaty profile: click here


<h2>Nuvaxovid; Protein</h2>
<h3>Novavax</h3>

Touch with the mouse pointer for more information.


<h2>Nuvaxovid</h2>
<h3>Novavax</h3>

Trade name: Nuvaxovid Manufacturer: Novavax Vaccine type: Protein-based vaccine (recombinant, adjuvanted) Approval since: 20.12.2021 Novavax profile: click here


<h2>COVID-19 Vaccine Moderna; mRNA</h2>
<h3>Moderna Biotech</h3>

Touch with the mouse pointer for more information.


<h2>COVID-19 Vaccine Moderna</h2>
<h3>Moderna Biotech</h3>

Trade name: COVID-19 Vaccine Moderna Manufacturer: Moderna Biotech Vaccine type: mRNA Authorization since: 06.01.2021 Spikevax profile: click here

THE STIKO CURRENTLY RECOMMENDS BOOSTER VACCINATIONS

for the following groups of people:

  • Adults over 60 years
  • Children from the age of 6 months, adolescents and adults, including pregnant women, with an underlying disease such as e.g: Asthma, COPD, cardiovascular, liver, kidney diseases, diabetes mellitus, obesity, neurological diseases, cancer or immunosuppression
  • Family members and close contacts from the age of 6 months of persons* who are not expected to have a protective immune response after COVID-19 vaccination
  • Residents of care facilities
  • Medical staff

Patienten
Informationen

Rezeptbestellung
Online

Terminbuchung
Online

Terminbuchung
Video-Sprechstunde